Therapeutic Antibodies Industrial trends 2015 - Biosimilars & Biosuperiors

on Tuesday, 7 April 2015 includes new market research report " Therapeutic Antibodies Market 2015 - Biosimilars & Biosuperiors: Industry Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection of research reports.

This Competitive Intelligence Report about Therapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products and as biosimilar versions as of April 2015.

Total sales of recombinant therapeutic monoclonal antibodies originating from companies located in regulated markets reached US$ 82.2 bln (+8.6% vs previous year) in the year 2014.

The report lists specifically for each target the branded products with their 2014 sales and up-side indications in development, as well as biosuperior and biosimilar antibody drug candidates in development.

The report includes a compilation of currently active projects in research and development of biosimilar and biosuperior therapeutic antibodies against commercially and clinically validated targets:
  • VEGF
  • TNF
  • Her2
  • CD20
  • EGF-R
  • B7.1/B7.2 (CD80/CD86)
  • IL-6R
  • Alpha4/beta1/7 integrin
  • IgE
  • RSV
  • Complement C5
  • IL-12/IL-23
  • CD52

Request a FREE copy of a SMAPLE REPORT at:

Competitor projects are listed in a tabular format providing information on:
  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.
Browse More reports related to Therapeutic Industry at:

About Us:

ResearchMoz ( ) is the one stop online destination to find and buy market research reports. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.

For More Information Kindly Contact: 
Mr. Nachiket
Toll Free: 866-997-4948


Post a Comment